Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Elodie, Coquan"'
Autor:
Kathleen Weyts, Justine Lequesne, Alison Johnson, Hubert Curcio, Aurélie Parzy, Elodie Coquan, Charline Lasnon
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Background [18F]FDG PET denoising by SubtlePET™ using deep learning artificial intelligence (AI) was previously found to induce slight modifications in lesion and reference organs’ quantification and in lesion detection. As a next step,
Externí odkaz:
https://doaj.org/article/591f339b927b4ba99200ce4a704ff064
Autor:
Isabelle L. Ray-Coquard, Aude-Marie Savoye, Camille Schiffler, Marie-Ange Mouret-Reynier, Olfa Derbel, Elsa Kalbacher, Marianne LeHeurteur, Alejandra Martinez, Corina Cornila, Mathilde Martinez, Leila Bengrine Lefevre, Frank Priou, Nicolas Cloarec, Laurence Venat, Frédéric Selle, Dominique Berton, Olivier Collard, Elodie Coquan, Olivia Le Saux, Isabelle Treilleux, Sophie Gouerant, Antoine Angelergues, Florence Joly, Olivier Tredan
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract This open-label, non-comparative, 2:1 randomized, phase II trial (NCT03275506) in women with stage IIIC/IV high-grade serous carcinoma (HGSC) for whom upfront complete resection was unachievable assessed whether adding pembrolizumab (200 mg
Externí odkaz:
https://doaj.org/article/caaac1537e0d490584c256cc9feb5b61
Autor:
Olivia Le Saux, Maude Ardin, Justine Berthet, Sarah Barrin, Morgane Bourhis, Justine Cinier, Yasmine Lounici, Isabelle Treilleux, Pierre-Alexandre Just, Guillaume Bataillon, Aude-Marie Savoye, Marie-Ange Mouret-Reynier, Elodie Coquan, Olfa Derbel, Louis Jeay, Suliman Bouizaguen, Intidhar Labidi-Galy, Séverine Tabone-Eglinger, Anthony Ferrari, Emilie Thomas, Christine Ménétrier-Caux, Eric Tartour, Isabelle Galy-Fauroux, Marc-Henri Stern, Magali Terme, Christophe Caux, Bertrand Dubois, Isabelle Ray-Coquard
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-15 (2024)
Abstract PD-1/PD-L1 blockade has so far shown limited survival benefit for high-grade ovarian carcinomas. By using paired samples from the NeoPembrOv randomized phase II trial (NCT03275506), for which primary outcomes are published, and by combining
Externí odkaz:
https://doaj.org/article/d3cea7027f5a444c832b3f2da46f8855
Autor:
Elodie Coquan, Nicolas Penel, Justine Lequesne, Raphaël Leman, Pernelle Lavaud, Zoé Neviere, Pierre-Emmanuel Brachet, Emeline Meriaux, Aurélien Carnot, Jérémy Boutrois, Marie Castera, Nicolas Goardon, Etienne Muller, Alexandra Leconte, Antoine Thiery-Vuillemin, Bénédicte Clarisse, Florence Joly
Publikováno v:
Therapeutic Advances in Urology, Vol 16 (2024)
Introduction: DNA damage repair genes are altered in 20–35% of metastatic castration-resistant prostate cancer (mCRPC). Poly-ADP (Adénosine Diphosphate)-ribose polymerase inhibitors (PARPi) showed significant activity for these selected tumors, es
Externí odkaz:
https://doaj.org/article/5a69b905bc4946d5bd1a26e1aca0aa30
Autor:
Nour‐El‐Houda Mourksi, Cécile Dalban, Amélie Colombe‐Vermorel, Laetitia Odeyer, Valentin Simioni, Jean‐Sébastien Frenel, Michel Fabbro, Fernando Bazan, Sophie Abadie‐Lacourtoisie, Elodie Coquan, Séverine Martinez, Gwenaelle Garin, Séverine Tabone‐Eglinger, Isabelle Treilleux, Sylvie Chabaud, David Pérol, Isabelle Ray‐Coquard, Pierre‐Etienne Heudel, Jean‐Jacques Diaz, Virginie Marcel
Publikováno v:
Molecular Oncology, Vol 17, Iss 1, Pp 27-36 (2023)
Resistance of advanced hormone‐dependent endometrial carcinoma to endocrine therapy remains a worldwide clinical issue. We recently reported that the combination of Vistusertib (V, mTOR inhibitor) and Anastrozole (A, aromatase inhibitor) improves t
Externí odkaz:
https://doaj.org/article/ae737b53e2ab4d899bf43ee577ab684b
Autor:
Elodie Coquan, Bénédicte Clarisse, Justine Lequesne, Pierre-Emmanuel Brachet, Zoé Nevière, Emeline Meriaux, Isabelle Bonnet, Marie Castera, Nicolas Goardon, Jeremy Boutrois, Romain Travers, Florence Joly, Jean-Michel Grellard, Antoine Thiery-Vuillemin
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Urothelial carcinoma (UC) is the ninth most commonly diagnosed cancer worldwide, with a 3.8/1 male to female ratio. Platinum-based chemotherapy is the first line standard of care for fit patients with advanced UC. However, despite
Externí odkaz:
https://doaj.org/article/acfbd3288d034b809da2abcad858ad21
Autor:
Zoé Neviere, Elodie Coquan, Pierre-Emmanuel Brachet, Emeline Meriaux, Isabelle Bonnet, Sophie Krieger, Laurent Castéra, Dominique Vaur, Flavie Boulouard, Alexandra Leconte, Justine Lequesne, Anais Lelaidier, Agathe Ricou, Florence Joly
Publikováno v:
Current Oncology, Vol 29, Iss 4, Pp 2776-2791 (2022)
(1) Background: In literature, approximately 20% of mCRPC present somatic DNA damage repair (DDR) gene mutations, and their relationship with response to standard therapies in mCRPC is not well understood. The objective was to evaluate outcomes of mC
Externí odkaz:
https://doaj.org/article/0e3b1c5231eb4699ae68cf6490534e95
Autor:
François Cherifi, Sophie Lefevre Arbogast, Jonaz Font, Cyril Abdeddaim, Stephanie Becourt, Nicolas Penel, Elodie Coquan, Justine Lequesne, Yori Gidron, Florence Joly
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveIdentifying new modifiable prognostic markers is important for ovarian cancer (OC). Low parasympathic activity is associated with inflammation, oxidative stress and sympathetic nervous system activation. Previous studies reported that low va
Externí odkaz:
https://doaj.org/article/4fa3cc2ceb7f47df9f271880fc3dd061
Autor:
Angélique Da Silva, Aude Fléchon, Elodie Coquan, François Planchamp, Stéphane Culine, Thibaut Murez, Arnaud Méjean, David Pasquier, Christine Chevreau, Karim Fizazi, Antoine Thiery-Vuilemin, Florence Joly
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Stage-I testicular germ-cell tumor (TGCT) has excellent cure rates. Surveillance is fully included in patient’s management, particularly during the first years of follow-up. Surveillance guidelines differ between the academic societies, mainly conc
Externí odkaz:
https://doaj.org/article/7340836fb6b64f13908d810fc059823d
Autor:
Elodie Coquan, Pierre-Emmanuel Brachet, Idlir Licaj, Alexandra Leconte, Marie Castera, Justine Lequesne, Emeline Meriaux, Isabelle Bonnet, Anais Lelaidier, Bénédicte Clarisse, Florence Joly
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Cervical cancer is the tenth diagnosed cancer in the world. Early-stage and locally recurrent disease may be cured with radical surgery or chemo-radiotherapy. However, if disease persists or recurs, options are limited and the pro
Externí odkaz:
https://doaj.org/article/a73be4e0e2134c96bf30ae824204c6fb